Non-Invasive Prenatal Testing (NIPT) Market to Grow at a Double Digit CAGR until 2025

Increasing interference of technology in the medical sector has enabled early diagnosis of pre-borne children which is expected to drive global non-invasive prenatal testing (NIPT) market

According to TechSci Research report, “Global Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others), By Product (Instruments, Kits and assay), By Technology (Cell free fetal DNA technology, Massively parallel sequencing, Target Capture Sequences Technology and others), By End User (Hospitals and diagnostic laboratory), By Region, Forecast & Opportunities, 2025”, global non-invasive prenatal testing (NIPT) market is expected to grow at a double-digit CAGR during the next five years. NIPT is a way to ensure the birth of a healthy child, who is free from any genetic disorders. This is done by testing small DNA fragments present in the blood of pregnant women. Additionally, the market is driven by the increase in gene and chromosome syndrome related cases, growing demand for timely or early fetal testing across the world and increasing healthcare expenditure. However, high cost of installation and lack of professionals might hamper the growth of the market.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “Global Non-invasive Prenatal Testing (NIPT) Market”

https://www.techsciresearch.com/report/non-invasive-prenatal-testing-nipt-market/4669.html

Global non-invasive prenatal testing (NIPT) market is segmented on the basis of application, product, technology, end user and region. The application segment is divided into trisomy, turner syndrome, Rh blood type and others. The trisomy segment is expected to lead the market in the next five years as the Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13) are quite prevalent and cases of genetic and chromosome disorders are increasing with time, which have contributed to the dominance of the segment.

In terms of end user, global non-invasive prenatal testing (NIPT) market can be bifurcated into hospitals and diagnostic laboratory. Hospitals are the major end users, where the NIPT systems are deployed, hence they are expected to occupy the dominant market share over the next five years.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4669

Customers can also request for 10% free customization on this report.

Leading players in the global non-invasive prenatal testing (NIPT) market include Roche, Integrated Genetics, Natera, BGI Genomics, Illumina, Invitae, Genesis Genomics, PerkinElmer, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Yourgene Health, Berry Genomics, Igenomix, Quest Diagnostics, Asper Biogene, Myriad Genetics, Progenity, Fasteris, Bionet Corp, etc. In order to expand their market share, the companies adopt various strategies like new product launches, collaborations and many more. Illumina is one of the leading companies in this market as it keeps on introducing products related to genotyping, sequencing, gene expression, among others to the market.

“North America is expected to dominate the market global non-invasive prenatal testing (NIPT) market during the next five years due to the early adoption of technologies in the region. Additionally, major reason for the dominance of this region is the strong financial support, which enables it to adopt and install new technologies and easily deploy them in major countries like United States, which reportedly held more than half the market share in 2019. Moreover, Asia-Pacific is anticipated to be the fastest growing region in the market on account of the rising awareness among the population about NIPT in the developing countries.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others), By Product (Instruments, Kits and assay), By Technology (Cell free fetal DNA technology, Massively parallel sequencing, Target Capture Sequences Technology and others), By End User (Hospitals and diagnostic laboratory), By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global non-invasive prenatal testing (NIPT) market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global non-invasive prenatal testing (NIPT) market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]